TERT and renal cell adenocarcinoma: Several lines of research suggest that rs2853669 suppresses the TERT promoter mutation-mediated TERT expression regulation and mortality or recurrence rates for bladder cancer [17], gliomas [21, 22], and renal cell cancer [23]; however, the mechanism by which TERT transcription is regulated remains unknown.